Advances in psychiatry and nuerology


ISSN 1234-8279

ISSN on-line 2449-9315 

 

As of July 2026, the journal's publisher is Wroclaw Medical University: https://ppn.umw.edu.pl/en/about/.

 

CiteScore 2025: 0.4

MNiSW: 20

Index Copernicus 2023: 90.54

Editorial panel
Submitting and reviewing works online
  • Home page
  • >
  • Archive
  • >
  • issue 2
  • >
  • Chronic psychotic disturbances and dementia in a patient with chronic hepatitis C following the treatment with pegylated interferon-α plus ribavirin. A case report

Archive 1995–2023

2006, volume 22, issue 2
Case report

Chronic psychotic disturbances and dementia in a patient with chronic hepatitis C following the treatment with pegylated interferon-α plus ribavirin. A case report

Wiktor Dróżdż, Alina Borkowska, Monika Wiłkość, Marta Tomaszewska, Waldemar Halota1, Małgorzata Pawłowska, Dorota Dybowska, Janusz Rybakowski1
1. Klinika Psychiatrii Dorosłych Akademii Medycznej w Poznaniu
Farmakoterapia w Psychiatrii i Neurologii, 2006, 2, 87–92
Keywords: dementia, hepatitis C, interferon-alpha, psychotic disturbances
Summary

We report on a 46-old patient with chronic hepatitis C in whom seven-month treatment with interferon-alpha plus ribavirin induced persistent psychotic disturbances and significant cognitive impairment that caused marked psychosocial deterioration. The disturbances appeared resistant to therapy with typical neuroleptics and subsequent treatment with clozapine plus quetiapine partially alleviated the symptoms. The latter drugs yielded distinct reduction of tension, auditory hallucinations, improvement of sleep quality and disappearance of suicidal impulses. However, serious impairment of cognitive functions on the level of mild dementia together with psychomotor slowness continued for more than a year. Good psychosocial premorbid functioning, negative personal and family psychiatric history, no substance abuse in the past suggest a relationship between therapy with interferon-alpha plus ribavirin and onset of psychosis and dementia. This may indicate irreversible brain damage in the aftermath of treatment with interferon-alpha plus ribavirin in susceptible individuals.

Correspondence address
Wiktor Dróżdż
Zakład Neuropsychologii Klinicznej Uniwersytetu Mikołaja Kopernika w Toruniu,
Collegium Medicum im. L. Rydygiera w Bydgoszczy
ul. Skłodowskiej 9, 85-094 Bydgoszcz
email: [email]wikdr@cm.umk.pl[/email]
You have added an item to your cart
Restore password
Shopping cart (0)
No products in your cart
Font size
Contrast
Underlined links